A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma

BACKGROUND: A phase II clinical trial previously evaluated the sequential administration of erlotinib after chemotherapy for advanced non-small-cell lung cancer (NSCLC). This current pilot study assessed the feasibility of sequential induction therapy in patients with stage IIB to IIIA NSCLC adenoca...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lv, Chao, Ma, Yuanyuan, Feng, Qin, Fang, Fang, Bai, Hua, Zhao, Bingtian, Yan, Shi, Wu, Nan, Zheng, Qingfeng, Li, Shaolei, Chen, Jinfeng, Wang, Jia, Feng, Yuan, Wang, Yuzhao, Pei, Yuquan, Fang, Jian, Yang, Yue
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3643858/
https://ncbi.nlm.nih.gov/pubmed/23621919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-11-96
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia